Table 1:

Baseline characteristics of patients (≥5 years) in pre-ART CD4 testing and viral load (VL) monitoring analyses by country.

	Lesotho	Malawi	Mozambique	South Africa	Zambia	Zimbabwe	Total
Pre-ART CD4 testing
Total patients	1,882 (100%)	13,876 (100%)	10,534 (100%)	23,817 (100%)	178,465 (100%)	7,254 (100%)	235,828 (100%)
Female	1,249 (66%)	8,921 (64%)	6,907 (66%)	16,540 (69%)	112,876 (63%)	4,710 (65%)	151,203 (64%)
Age in years
median (IQR)	35 (28–46)	33 (26–41)	31 (25–40)	33 (27–41)	33 (27–40)	34 (26–42)	33 (27–40)
≤15	67 (4%)	688 (5%)	235 (2%)	337 (1%)	6,085 (3%)	484 (7%)	7,896 (3%)
16–24	231 (12%)	2,401 (17%)	2,486 (24%)	3,248 (14%)	29,018 (16%)	1,191 (16%)	38,575 (17%)
≥25	1,584 (84%)	10,787 (78%)	7,813 (74%)	20,232 (85%)	143,362 (81%)	5,579 (77%)	189,357 (80%)
With pre-ART CD4 testing	896 (48%)	2,334 (17%)	5,211 (50%)	19,857 (83%)	61,852 (35%)	2,300 (32%)	92,450 (39%)
VL monitoring
Total patients	1,309 (100%)	9,915 (100%)	7,295 (100%)	15,616 (100%)	109,536 (100%)	5,975 (100%)	149,646 (100%)
Female	861 (66%)	6,493 (66%)	4,921 (68%)	10,743 (69%)	69,687 (64%)	3,865 (65%)	96,570 (65%)
Age in years
median (IQR)	36 (28–46)	33 (26–41)	31 (25–41)	34 (28–42)	33 (27–40)	35 (27–43)	33 (27–41)
≤15	47 (4%)	514 (5%)	179 (2%)	141 (1%)	4,097 (4%)	423 (7%)	5,401 (4%)
16–24	157 (12%)	1,582 (16%)	1,608 (22%)	1,887 (12%)	16,193 (15%)	843 (14%)	22,270 (15%)
≥25	1,105 (84%)	7,819 (79%)	5,508 (76%)	13,588 (87%)	89,246 (81%)	4,709 (79%)	121,975 (81%)
With VL monitoring	20 (2%)	1,010 (10%)	254 (4%)	12,323 (79%)	12,746 (12%)	260 (4%)	26,613 (18%)

Abbreviation: IQR, interquartile range.

Number of patients (%) are shown unless otherwise indicated.